Direct assessment of the effect of cardiomyocyte-specific Rac1 deletion on cardiac structure, function, and signaling in response to established physiologic hypertrophy models such as chronic swimming and running would provide important context to the rationale of targeting Rac1 for heart disease. This evidence concerns the gene RAC1 and heart disorder.